Nicolle Davis: Celebrating the Team Behind Life-Saving Mobile Stroke Care
Nicolle Davis, Director of Mobile Stroke Program at UF Health, shared on LinkedIn:
”This week, we hosted our very first Mobile Stroke Team Building Day, bringing together all three Mobile Stroke Treatment Units for a truly special and memorable experience!
As part of this transformative day, we had the opportunity to capture team photos before spending the afternoon focused on fellowship, camaraderie, and team-building activities.
Having our entire Mobile Stroke team together in one place was both surreal and inspiring.
Every day, these dedicated professionals make a meaningful impact in the communities we serve.
Their passion, commitment to excellence, and unwavering dedication to providing life-saving stroke care are unmatched.
We are incredibly proud of this team and all they accomplish.
Be on the lookout for our official fleet and team photographs in the coming weeks!
Until then, enjoy this behind-the-scenes glimpse of our amazing team and their Gator Pride!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics
-
Nov 14, 2026, 23:33Alexandros Makis: Exploring Vascular Mechanisms and Therapeutic Targets in β-Thalassemia